Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
NCT04368442
·
clinicaltrials.gov ↗
UNKNOWN
Status
583
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Metastatic
Sponsor
Samsung Medical Center